Factors influencing vertebral bone density after renal transplantation.
To improve our understanding of the mechanisms underlying osteoporosis following renal transplantation, we compared bone mineral density (BMD) in 158 transplant recipients and in 293 patients undergoing maintenance hemodialysis with age- and sex-matched normal controls. Observations in graft recipients were made up to several years following transplantation. Dual-energy X-ray absorptiometry was used to measure BMD. Correlations with clinical variables including serum concentration of parathyroid hormone (PTH) and steroid therapy were evaluated. Lumbar BMD was lower in transplant patients than in dialysis patients at all ages, and continued to decrease with increasing interval posttransplant until the second year after transplantation. Persistent hyperparathyroidism and daily prednisolone dosage were both associated with decreased BMD. Age and creatinine clearance were independent long-term predictors of BMD by multiple regression analysis. Treatment of renal graft recipients with calcium and vitamin D supplements or calcitonin may be indicated in the early months after transplantation.
Kokado
Y
Y
Department of Urology, Osaka University Medical School, Suita, Japan.
Takahara
S
S
Ichimaru
N
N
Toki
K
K
Kyo
M
M
Permpongkosol
S
S
Kojima
Y
Y
Inoue
T
T
Wang
J D
JD
Okuyama
A
A
D015502:Absorptiometry, Photon; D000328:Adult; D000367:Age Factors; D015519:Bone Density; D005260:Female; D006801:Humans; D007676:Kidney Failure, Chronic / Q000503:physiopathology / Q000628:therapy; D016030:Kidney Transplantation / Q000502:physiology*; D008159:Lumbar Vertebrae; D008297:Male; D008875:Middle Aged; D010281:Parathyroid Hormone / Q000097:blood; D011884:Radius; D012016:Reference Values; D012044:Regression Analysis; D006435:Renal Dialysis; D012737:Sex Factors; D014511:Uremia / Q000503:physiopathology / Q000628:therapy
D010281:Parathyroid Hormone